Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nowy Targ – page 3

31 clinical trials in Nowy Targ, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nowy Targ at a glance
31
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

31 trials in Nowy Targ

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Naronapride Dihydrochloride Trihydrate
  • Sponsor:Dr. Falk Pharma GmbH

Crohn's disease

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nowy Targ

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Multiple clinical trials focusing on ulcerative colitis and Crohn's disease treatments, evaluating novel therapeutic agents including obefazimod, rosnilimab, and TEV-48574 for patients with moderate to severe conditions.

  • Induction and maintenance therapy studies
  • Long-term safety evaluations
  • Novel therapeutic approaches

These studies aim to improve treatment options for patients who haven't responded well to conventional therapies.

02 Cardiovascular Studies

Groundbreaking research investigating treatments for atherosclerotic cardiovascular disease and acute coronary syndrome, including studies on inclisiran and antiplatelet strategies.

  • Cardiovascular death prevention
  • Stroke risk reduction
  • Antiplatelet therapy optimization

These trials focus on reducing major adverse cardiovascular events and improving patient outcomes.

03 Gastrointestinal and Rheumatic Conditions

Innovative research examining treatments for gastroparesis and psoriatic arthritis, testing medications like naronapride and deucravacitinib.

  • Delayed stomach emptying treatments
  • Arthritis management strategies
  • Disease-modifying therapies

These studies aim to address both digestive system disorders and inflammatory joint conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.